Kerendia (Finerenone)

Finerenone is a medicine that helps protect the kidneys and heart in people with diabetes-related kidney disease and in some people with heart failure. It is taken as a pill once a day. It works by blocking a hormone signal that can cause swelling and scarring in the kidneys and heart.

Brand names:Kerendia
Medication

What people taking Kerendia (Finerenone) report

Every report comes from a Lived member, sent anonymously.

Have you tried Kerendia (Finerenone) for Diabetic Kidney Disease?

NameHow it went

About Kerendia (Finerenone)

What It's For

Finerenone, sold as Kerendia, is a once-daily prescription tablet that helps protect the kidneys and heart. It is approved for adults in three situations. In adults with chronic kidney disease caused by type 2 diabetes, it lowers the risk that kidney function keeps declining or reaches kidney failure, and it lowers the risk of heart attack, death from heart disease and hospital stays for heart failure. In adults with kidney disease caused by type 1 diabetes, it is approved because it reduces albumin (a protein that leaks into the urine when the kidneys' filters are damaged). Less albumin is expected to mean slower kidney damage, although that longer-term benefit has not yet been measured directly in people with type 1 diabetes. In adults with heart failure whose ejection fraction (the share of blood the main pumping chamber pushes out with each beat) is 40% or higher, it reduces hospital stays and urgent visits for worsening heart failure. Finerenone is usually added to other treatments rather than used alone. In diabetes-related kidney disease, it typically sits on top of a kidney-protecting blood pressure medicine, either an ACE (angiotensin-converting enzyme) inhibitor or an ARB (angiotensin receptor blocker), and often an SGLT2 inhibitor, a diabetes medicine that also protects the kidneys. It has not been studied enough in people under 18 to be used in children.

How It Works

Aldosterone is a hormone that tells the kidneys to hold on to salt and water. It acts by switching on a target called the mineralocorticoid receptor, which is found in the kidneys, heart and blood vessels. When this receptor is switched on too much, as often happens in diabetes, kidney disease and heart failure, it promotes inflammation and scarring (fibrosis) that gradually damages these organs. Finerenone blocks the mineralocorticoid receptor, which calms that inflammation and scarring. It belongs to a group called mineralocorticoid receptor antagonists, along with the older medicines spironolactone and eplerenone. Unlike those two, it does not have a steroid structure, and it targets this one receptor selectively, with no meaningful action on sex hormone receptors. It lowers blood pressure only slightly, so its protective effect is not simply a blood pressure effect. Because blocking this receptor also makes the kidneys hold on to potassium, finerenone can raise blood potassium. That trade-off shapes how it is started and monitored.

Dosage & Administration

Kerendia comes as 10 mg, 20 mg and 40 mg tablets taken by mouth once a day, with or without food. Taking it at about the same time each day makes it easier to remember. If swallowing a whole tablet is difficult, it can be crushed and mixed with water or a soft food such as applesauce, then taken right away. Before starting, the prescriber checks a blood test for potassium and kidney function, measured as eGFR (estimated glomerular filtration rate, a number that reflects how well the kidneys filter blood; lower numbers mean weaker kidney function). Finerenone is not started if potassium is above 5.0 or if eGFR is below 25. People with better kidney function usually start at 20 mg and those with lower function at 10 mg. About 4 weeks later the blood test is repeated, and the dose is raised, kept the same or paused depending on the potassium result. For kidney disease the usual target is 20 mg a day; for heart failure it can be 20 mg or 40 mg, depending on kidney function. If a dose is missed, take it as soon as you remember, but only on the same day. Otherwise skip it and take the next dose as usual; do not double up.

Side Effects

The most important side effect is a high blood potassium level, called hyperkalemia. In the main kidney trials it showed up on blood tests in about 14% of people taking finerenone compared with about 7% on placebo, and fewer than 1 in 100 needed a hospital stay for it. It is more likely when kidney function is lower or potassium was already on the high side. High potassium often causes no symptoms, which is why routine blood tests matter. Muscle cramps, unusual weakness or fatigue are reasons to contact the care team promptly. Palpitations, a slow or irregular pulse, chest pain, trouble breathing or fainting can signal a dangerously high potassium level and need emergency care. Some people feel dizzy or lightheaded because blood pressure drops a little, and blood sodium can run low. Kidney function numbers often dip slightly in the first month and then settle; this small change is expected. In people with heart failure, though, finerenone more often caused a meaningful worsening of kidney function, occasionally serious enough to need a hospital stay, so eGFR is rechecked when starting and after dose increases. Allergic reactions, including hives, rash and swelling, have been reported rarely. Swelling of the face, lips, tongue or throat that affects breathing or swallowing needs emergency care.

Interactions & Warnings

Finerenone is broken down mainly by a liver enzyme called CYP3A4, so medicines that block or speed up this enzyme change how much finerenone stays in the body. It must not be combined with strong blockers of CYP3A4, which include the antifungal medicines itraconazole, ketoconazole and voriconazole, the antibiotic clarithromycin, and some HIV medicines such as ritonavir. Grapefruit and grapefruit juice should be avoided for the same reason. Moderate blockers, such as erythromycin (an antibiotic) and verapamil (a heart and blood pressure medicine), call for extra potassium checks. Medicines that speed up the enzyme, such as rifampin (an antibiotic used for tuberculosis) and efavirenz (an HIV medicine), can make finerenone much less effective and should be avoided. Anything else that raises potassium adds to the risk. Talk to the prescriber before using potassium supplements or salt substitutes that contain potassium. Other potassium-raising medicines, including ACE inhibitors and ARBs that are often taken alongside finerenone, usually mean more frequent blood tests rather than stopping either drug. Finerenone should not be used by people with adrenal insufficiency (adrenal glands that do not make enough hormones) or severe liver disease. There are no human data in pregnancy, and animal studies showed harm to developing offspring, so anyone pregnant or planning a pregnancy should discuss it with the prescriber. Breastfeeding should be avoided during treatment and for one day after the last dose.

What to Expect

Finerenone is meant to prevent future harm rather than to make you feel different. Most people notice nothing day to day. The benefit shows up over years as fewer kidney and heart problems: in a major trial of people with kidney disease and type 2 diabetes, about 18% of those on finerenone had serious worsening of kidney disease over roughly two and a half years, compared with about 21% on placebo. In heart failure, it reduced repeat hospital stays and urgent visits but did not clearly lower the risk of dying from heart disease. Albumin in the urine usually drops within a few months, which gives the care team an early sign it is working. The first months involve blood tests for potassium and kidney function, starting about 4 weeks after the first dose and after each dose change. Once results are stable, tests become less frequent but continue for as long as you take it. Treatment is generally long term, since the aim is to keep lowering risk over years. If potassium climbs too high, the dose may be paused and restarted lower rather than stopped for good.

Questions to Ask Your Doctor

  1. 1.What do you expect finerenone to add to the kidney or heart medicines I already take?
  2. 2.What are my current potassium and eGFR numbers, and how often will they be checked?
  3. 3.Do any of my other medicines, supplements or salt substitutes raise my potassium or interact with finerenone?
  4. 4.What should I do if a test shows my potassium is high, or if I need an antibiotic or antifungal?
  5. 5.If I am planning a pregnancy or breastfeeding, what are my options?

Last reviewed • Oct 2026

Educational content, not medical advice.